362 related articles for article (PubMed ID: 8561142)
1. Risk factors of colorectal cancer in inflammatory bowel disease.
Bansal P; Sonnenberg A
Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
[TBL] [Abstract][Full Text] [Related]
2. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
4. Military history of patients with inflammatory bowel disease: an epidemiological study among U.S. veterans.
Delcò F; Sonnenberg A
Am J Gastroenterol; 1998 Sep; 93(9):1457-62. PubMed ID: 9732925
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
[TBL] [Abstract][Full Text] [Related]
7. Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening.
Zisman AL; Nickolov A; Brand RE; Gorchow A; Roy HK
Arch Intern Med; 2006 Mar; 166(6):629-34. PubMed ID: 16567601
[TBL] [Abstract][Full Text] [Related]
8. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
Bernstein CN; Blanchard JF; Metge C; Yogendran M
Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer prognosis among patients with inflammatory bowel disease.
Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
[TBL] [Abstract][Full Text] [Related]
10. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of fish consumption on colorectal cancer risk. Hospital-based case-control study in Eastern Europe.
Jedrychowski W; Maugeri U; Pac A; Sochacka-Tatara E; Galas A
Ann Nutr Metab; 2008; 53(3-4):295-302. PubMed ID: 19169007
[TBL] [Abstract][Full Text] [Related]
12. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
14. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
Bernstein CN; Nugent Z; Blanchard JF
Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
[TBL] [Abstract][Full Text] [Related]
15. Distress among inflammatory bowel disease patients at high risk for colorectal cancer: a preliminary investigation of the effects of family history of cancer, disease duration, and perceived social support.
Rini C; Jandorf L; Valdimarsdottir H; Brown K; Itzkowitz SH
Psychooncology; 2008 Apr; 17(4):354-62. PubMed ID: 17607717
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
[TBL] [Abstract][Full Text] [Related]
17. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.
Nguyen GC; Sam J
Am J Gastroenterol; 2008 Sep; 103(9):2272-80. PubMed ID: 18684186
[TBL] [Abstract][Full Text] [Related]
18. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
[TBL] [Abstract][Full Text] [Related]
19. Colorectal carcinoma: correlation between age, gender and subsite distribution.
Efremidou EI; Liratzopoulos N; Papageorgiou SM; Romanidis K; Tourlis T; Kouklakis G; Manolas KJ
Chirurgia (Bucur); 2008; 103(6):659-63. PubMed ID: 19274910
[TBL] [Abstract][Full Text] [Related]
20. Long-term use of statins and risk of colorectal cancer: a population-based study.
Singh H; Mahmud SM; Turner D; Xue L; Demers AA; Bernstein CN
Am J Gastroenterol; 2009 Dec; 104(12):3015-23. PubMed ID: 19809413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
